Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Micell Technologies Receives CE Mark Approval for MiStent SES

07:11 EDT 12 Jun 2013 | PR Newswire
This article has expired, however you can still download the PDF.
Preview:
DURHAM, N.C., June 12, 2013 /PRNewswire/ -- Micell Technologies, Inc. received CE (Conformite Europeenne) Mark approval for its MiStent® Sirolimus Eluting Absorbable Polymer Coronary Stent System (MiStent SES®) introducing a thin-strut stent that...

Other Sources for this Article

NEXT ARTICLE

More From BioPortfolio on "Micell Technologies Receives CE Mark Approval for MiStent SES"

Search BioPortfolio:
Advertisement
Advertisement

Searches Linking to this Story